Kerry acquires Proexcar S.A.S.

Kerry Group PLC
31 May 2023
 
 

31 May 2023

LEI: 635400TLVVBNXLFHWC59

 

KERRY GROUP

Kerry acquires Proexcar S.A.S.

Kerry Group plc ("Kerry"), the global taste & nutrition company, announces it has acquired 100% of the share capital of Proexcar S.A.S. ("Proexcar") for an initial consideration of US$44m subject to routine closing adjustments, with a potential additional payment of up to US$18m payable in 2025 based on achieving earn-out conditions. Located in Colombia with c. 120 employees, the company has leading natural functional systems technologies, which can deliver clean label solutions into protein applications. This acquisition strengthens Kerry's offering and leadership position within the overall LATAM meat market, while also providing a platform for strategic development within the ANDEAN region.

ENDS

 

About Kerry

Kerry is a world leading taste and nutrition partner for the food, beverage and pharmaceutical markets. We innovate with our customers to create great tasting products, with improved nutrition and functionality, while ensuring better impact for the planet. Our leading consumer insights, global RD&A team of 1,100+ food scientists and extensive global footprint enable us to solve our customers' complex challenges with differentiated solutions. At Kerry, we are driven to be our customers' most valued partner, creating a world of sustainable nutrition, and to reach over 2 billion consumers with sustainable nutrition solutions by 2030. For more information, visit www.kerry.com.

 

 

 

 

CONTACT INFORMATION

 




Investor Relations

Marguerite Larkin, Chief Financial Officer

+353 66 7182292 | investorrelations@kerry.ie

 


 


William Lynch, Head of Investor Relations



+353 66 7182292 | investorrelations@kerry.ie


 

Media

 

Catherine Keogh, Chief Corporate Affairs & Brand Officer

 


+353 45 930188 | corpaffairs@kerry.com





Website

 

www.kerry.com

 




 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings